Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Jan 15, 2022; 14(1): 55-74
Published online Jan 15, 2022. doi: 10.4251/wjgo.v14.i1.55
Published online Jan 15, 2022. doi: 10.4251/wjgo.v14.i1.55
Site | Malignant cell type | H. pylori effect | Odds ratio | 95%CI | P value | Gastrointestinal transit time |
Oral cavity | Squamous cell carcinoma | Non related | 1 min | |||
Pharynx-larynx | Squamous cell carcinoma | Increased risk1 | 2.87 | 1.71-4.84 | < 0.05 | 1 s |
Oesophagus | Squamous cell carcinoma | Non related | 4-8 s | |||
Adenocarcinoma | Protected effect | 0.56 | 0.46-0.68 | < 0.05 | ||
Stomach | Adenocarcinoma | Cause-effect | 5.9 | 3.4-10.3 | < 0.05 | 2-4 h |
MALT lymphoma | Cause-effect | 1.96 | 1.0-3.9 | < 0.05 | ||
Small intestine | Lymphoma | Non related | 6 h | |||
Colorectum | Adenocarcinoma | Partial cause-effect | 1.7 | 1.64-1.76 | < 0.05 | 10 h to days |
Lymphoma | Non related |
- Citation: Kuo YC, Yu LY, Wang HY, Chen MJ, Wu MS, Liu CJ, Lin YC, Shih SC, Hu KC. Effects of Helicobacter pylori infection in gastrointestinal tract malignant diseases: From the oral cavity to rectum. World J Gastrointest Oncol 2022; 14(1): 55-74
- URL: https://www.wjgnet.com/1948-5204/full/v14/i1/55.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i1.55